“Endothelial Progenitor Cells” as a Therapeutic Strategy in Cardiovascular Disease

Publisher： Bentham Science Publishers

E-ISSN： 1875-6212|10|1|107-124

ISSN： 1570-1611

Source： Current Vascular Pharmacology, Vol.10, Iss.1, 2012-01, pp. : 107-124

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Potential of Endothelial Progenitor Cells for Cardiovascular Diseases

By  

Current Vascular Pharmacology, Vol. 4, Iss. 1, 2006-01 ,pp. : 59-65

Bentham Science Publishers

Access to resources Recommend Favorite

Genetically Modified Endothelial Progenitor Cells in the Therapy of Cardiovascular Disease and Pulmonary Hypertension

By  

Current Vascular Pharmacology, Vol. 10, Iss. 3, 2012-05 ,pp. : 289-299

Bentham Science Publishers

Access to resources Recommend Favorite

Transplantation of endothelial progenitor cells for therapeutic neovascularization

By Kawamoto A.   Asahara T.   Losordo D.W.  

Cardiovascular Radiation Medicine, Vol. 3, Iss. 3, 2002-07 ,pp. : 221-225

Elsevier

Access to resources Recommend Favorite

When Cells Become a Drug. Endothelial Progenitor Cells for Cardiovascular Therapy: Aims and Reality

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 5, Iss. 1, 2010-01 ,pp. : 1-10

Bentham Science Publishers

Access to resources Recommend Favorite

Circulating endothelial progenitor cells as a link between synovial vascularity and cardiovascular mortality in rheumatoid arthritis

By Akhavani M. A.   Larsen H.   Paleolog E.  

Scandinavian Journal of Rheumatology, Vol. 36, Iss. 2, 2007-01 ,pp. : 83-90

Informa Healthcare

Access to resources Recommend Favorite